Live Breaking News & Updates on Prelude Therapeutic

Stay updated with breaking news from Prelude therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Here's Why We're Watching Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the. ....

Prelude Therapeutics , Prelude Therapeutic , Free Cash Flow ,

Prelude Therapeutics Incorporated (NASDAQ:PRLD) is definitely on the radar of hedge funds investors who own 33% of the company

Key Insights Given the large stake in the stock by institutions, Prelude Therapeutics' stock price might be vulnerable. ....

Krishna Vaddi , Prelude Therapeutics Incorporated , Prelude Therapeutic , Prelude Therapeutics , Nstitutional Ownership , Institutional Investors , Hedge Funds , Prelude Therapeutics ,

HC Wainwright Weighs in on Prelude Therapeutics Incorporated's Q1 2024 Earnings (NASDAQ:PRLD)

Prelude Therapeutics Incorporated (NASDAQ:PRLD – Free Report) – Stock analysts at HC Wainwright issued their Q1 2024 earnings estimates for Prelude Therapeutics in a research note issued on Thursday, August 17th. HC Wainwright analyst R. Burns forecasts that the company will earn ($0.61) per share for the quarter. HC Wainwright currently has a “Buy” rating […] ....

United States , Prelude Therapeutics Incorporated , Blackrock Inc , Orbimed Advisors Llc , America Corp , Morgan Stanley , Vanguard Group Inc , Free Report , Prelude Therapeutics , Prelude Therapeutic , Therapeutics Trading Down , Director Orbimed Advisors Llc , Get Free Report , Therapeutics Incorporated , Prelude Therapeutics Daily , Nasdaq Prld , Earnings Estimates , Hc Wainwright ,

We Think Prelude Therapeutics (NASDAQ:PRLD) Needs To Drive Business Growth Carefully

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the. ....

Prelude Therapeutics , Prelude Therapeutic ,

Prelude Therapeutics Incorporated (NASDAQ:PRLD) Expected to Post Earnings of -$0.74 Per Share

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

United States , Hong Kong , Morgan Stanley , Zacks Investment Research , Prelude Therapeutics Incorporated , Prelude Therapeutics Company Profile Get Rating , Wells Fargo Company , Group Plc , Royal Bank , Hong Kong Ltd , Get Rating , Prelude Therapeutic , Prelude Therapeutics , Kong Ltd , General Group Plc , Therapeutics Company Profile , Therapeutics Incorporated ,